Similar articles

• Evaluation of factors involved in calcium stone formation.

  Abraham PA, Smith CL. Abraham PA, et al. Miner Electrolyte Metab. 1987;13(3):201-8. Miner Electrolyte Metab. 1987. PMID: 3627051
• Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.

  Alvarez Arroyo MV, Traba ML, Rapado A. Alvarez Arroyo MV, et al. Urol Int. 1992;48(3):342-6. Urol Int. 1992. PMID: 1589930
• Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.

  Singh P, Enders FT, Vaughan LE, Bergstralh EJ, Knoedler JJ, Krambeck AE, Lieske JC, Rule AD. Singh P, et al. Mayo Clin Proc. 2015 Oct;90(10):1356-65. doi: 10.1016/j.mayocp.2015.07.016. Epub 2015 Sep 6. Mayo Clin Proc. 2015. PMID: 26349951 Free PMC article.
• Biopathological crystallization: a general view about the mechanisms of renal stone formation.

  Grases F, Costa-Bauzá A, García-Ferragut L. Grases F, et al. Adv Colloid Interface Sci. 1998 Feb;74:169-94. doi: 10.1016/s0001-8686(97)00041-9. Adv Colloid Interface Sci. 1998. PMID: 9561720 Review.
• The hyperuricosuric calcium oxalate stone former.

  Sarig S. Sarig S. Miner Electrolyte Metab. 1987;13(4):251-6. Miner Electrolyte Metab. 1987. PMID: 3306317 Review.